US 8685404
Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
granted A61KA61K2039/605A61K39/0007
Quick answer
US patent 8685404 (Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction) held by United States Government as represented by the Department of Veterans Affairs expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States Government as represented by the Department of Veterans Affairs
- Grant date
- Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2039/605, A61K39/0007, A61K39/0013, A61K45/06